Literature DB >> 12368039

Hierarchical immunogenicity of donor MHC class I peptides in allotransplantation.

Ana Gabriela Sitaru1, Wolfgang Timmermann, Karin Ulrichs, Christoph Otto.   

Abstract

The recognition of major histocompatibility complex (MHC) allopeptides by recipient MHC class II-restricted CD4(+) T cells via indirect pathway is a prerequisite for the generation of an immune response to the allograft. We tested 13-mer to 24-mer peptides from the MHC class I molecule for their possible immunogenicity in a fully MHC-mismatched rat strain combination. Our results confirm the hierarchical distribution of the immunogenicity of donor MHC class I peptides in the T cell alloactivation via indirect pathway. In addition, we show that allopeptide-induced immune response is critical for acute rejection of heart allografts. Among the seven allopeptides tested, peptide P1 was identified as immunodominant; it induced the greatest T cell proliferation and cytokine production in vitro as well as a significant reduction in allograft survival time. The TCR repertoire of T cells involved in the in vitro and in vivo responses induced by the dominant allopeptide P1 was found to be limited to the Vbeta10 and Vbeta 19 gene families. The identification of dominant allopeptides should greatly facilitate characterization of the specific T cell population responsible for allograft rejection and may be used to modulate the alloimmune response through antigen-specific therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368039     DOI: 10.1016/s0198-8859(02)00452-4

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  2 in total

1.  Intragraft selection of the T cell receptor repertoire by class I MHC sequences in tolerant recipients.

Authors:  Dahai Liu; Xiu-Da Shen; Yuan Zhai; Wengsi Lam; Jingying Liao; Ronald W Busuttil; Rafik M Ghobrial
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

2.  The Transcription Factor NFATc1 Supports the Rejection of Heterotopic Heart Allografts.

Authors:  Johannes Baur; Christoph Otto; Ulrich Steger; Stefan Klein-Hessling; Khalid Muhammad; Tobias Pusch; Krisna Murti; Rhoda Wismer; Christoph-Thomas Germer; Ingo Klein; Nora Müller; Edgar Serfling; Andris Avots
Journal:  Front Immunol       Date:  2018-06-12       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.